Researchers Mapped Immune Cells in IBD Patients
A new ChipCytometry platform has revealed distinct immune cell signatures in ulcerative colitis and Crohn's disease.
Updated on Sept. 24, 2026 in Allergies
Scientists have utilized a multiplex ChipCytometry platform to profile immune cells within colonic tissues. This approach identified specific cellular differences between ulcerative colitis and Crohn's disease patients compared to healthy volunteers.
Why it matters
Understanding how immune cells infiltrate and activate within the colon is critical, as these processes are primary drivers of inflammatory bowel disease pathology. Mapping these cells could eventually assist in differentiating between disease types.
The study utilized a 20-marker panel to image colonic tissues from 2 healthy volunteers, 5 ulcerative colitis patients, and 5 Crohn's disease patients. Researchers quantified immune cell subsets and S1P1 expression via bivariate gating.
The details
The platform analyzes formalin-fixed paraffin-embedded tissues to track immune cell movement and activation. Findings showed that ulcerative colitis samples featured higher T-cell and S1P1-positive immune cell counts, while Crohn's disease samples were marked by increased plasma cell abundance, with both conditions showing reduced natural killer cell frequencies.
Timeline
September 24, 2026: Study results were published online.
The Big Picture
This study follows the methodology established by the Human Cell Atlas project by cataloging immune cell populations in human tissue at high resolution. By identifying specific markers in diseased tissue, this work extends the project's goal of creating comprehensive cellular maps.
While this research remains in the discovery phase, identifying specific immune signatures may eventually lead to more precise diagnostic tools for patients with gastrointestinal inflammation. Such advancements could enable doctors to better distinguish between IBD subtypes for personalized care.
The takeaway
These findings suggest that inflammatory bowel disease involves complex, distinct shifts in immune cell populations within the colon. Continued research into these cellular markers is essential for developing targeted therapies that address specific types of gut inflammation.
Further reading
Learn more about the latest research regarding Allergies.
